Company · Public · RXRX
Recursion Pharmaceuticals
Industrial-scale cellular imaging paired with machine learning to map biology and generate candidates.
EvidenceModeratePlatform expansion
Listing
Public
Ticker
RXRX
Headquarters
Salt Lake City, US
Founded
2013
Technology
Phenomics + ML drug discovery
Category
Market cap
$2.9B
Longevity thesis
Owning the data-generation layer, not just the model, is the durable advantage in AI discovery.
Pipeline
| Programme | Stage | Focus |
|---|---|---|
| REC-4881 | Phase 2 | Familial adenomatous polyposis |
| Senescence map | Discovery | Cellular aging phenotypes |
Recent developments
- 21 Jul 2026Released expanded senescence phenotype maps to academic partners.
Scientific evidence
EvidenceModerate
Platform validation stronger than clinical validation to date.
LONGEFI analysis
Useful as infrastructure exposure to aging biology rather than as a bet on any single longevity asset.
Analysis is research commentary. It is not investment advice or a recommendation.